Anonymous
×
Create a new article
Write your page title here:
We currently have 205 articles on Shadowrun Seattle Shutdown. Type your article name above or click on one of the titles below and start writing!



Shadowrun Seattle Shutdown
in:

Drugs/Addiction Example: Difference between revisions

No edit summary
No edit summary
Line 2: Line 2:
[[Character:Shirayuri]] may be a full-limb-replacement cyborg, but she doesn't have wired reflexes, so she makes use of Jazz{{src|sr5|ref=411}} to get her speed boost.
[[Character:Shirayuri]] may be a full-limb-replacement cyborg, but she doesn't have wired reflexes, so she makes use of Jazz{{src|sr5|ref=411}} to get her speed boost.


When she initially takes the drug, she starts a two week clock (10-8=2). If she avoids taking Jazz for the next two weeks, the threshold will have had a chance to drop twice. At the end of that time she'll make two Addiction Tests because Jazz's Addiction Type is both &mdash; one using her LOG (3) + WIL (7), one using her BOD (3) + WILL (7)<ref>With an additional -2 for her Implant-Induced Immune Deficiency, anyway.</ref>, both against Threshold 1 (Jazz's base of 3, minus two weeks of drop-off). It should be easy for the cyber-singularity seeker. However, she's currently in the [[SCIRE]] during the shutdown. She'll almost certainly be taking Jazz on a regular basis. That means she'll never have a chance really get it out of her system. It'll probably be Threshold 3. Good luck!
When she initially takes the drug, she starts a two week clock (10-8=2). If she avoids taking Jazz for the next two weeks, the threshold will have had a chance to drop twice. At the end of that time she'll make two Addiction Tests because Jazz's Addiction Type is both &mdash; one using her LOG (3) + WIL (7), one using her BOD (3) + WILL (7)<ref>With an additional -2 for her Implant-Induced Immune Deficiency, anyway. {{src|cf|58}}</ref>, both against Threshold 1 (Jazz's base of 3, minus two weeks of drop-off). It should be easy for the cyber-singularity seeker. However, she's currently in the [[SCIRE]] during the shutdown. She'll almost certainly be taking Jazz on a regular basis. That means she'll never have a chance really get it out of her system. It'll probably be Threshold 3. Good luck!


If she were to take something more hardcore, like Kamikaze{{src|sr5|ref=412}}, the first Addiction Test would be only a week later (10-9=1) and be Threshold 3, because she hasn't had a full week off it to lower it.
If she were to take something more hardcore, like Kamikaze{{src|sr5|ref=412}}, the first Addiction Test would be only a week later (10-9=1) and be Threshold 3, because she hasn't had a full week off it to lower it.

Revision as of 16:51, 8 November 2022

Icon-warning.svg

This page is a Stub, meant to be transcluded into Addiction rather than viewed directly.

Character:Shirayuri may be a full-limb-replacement cyborg, but she doesn't have wired reflexes, so she makes use of Jazz[1] to get her speed boost.

When she initially takes the drug, she starts a two week clock (10-8=2). If she avoids taking Jazz for the next two weeks, the threshold will have had a chance to drop twice. At the end of that time she'll make two Addiction Tests because Jazz's Addiction Type is both — one using her LOG (3) + WIL (7), one using her BOD (3) + WILL (7)[2], both against Threshold 1 (Jazz's base of 3, minus two weeks of drop-off). It should be easy for the cyber-singularity seeker. However, she's currently in the SCIRE during the shutdown. She'll almost certainly be taking Jazz on a regular basis. That means she'll never have a chance really get it out of her system. It'll probably be Threshold 3. Good luck!

If she were to take something more hardcore, like Kamikaze[3], the first Addiction Test would be only a week later (10-9=1) and be Threshold 3, because she hasn't had a full week off it to lower it.

  1. Shadowrun Fifth Edition Core Rulebook (p. 411)
  2. With an additional -2 for her Implant-Induced Immune Deficiency, anyway. Chrome Flesh (p. 58)
  3. Shadowrun Fifth Edition Core Rulebook (p. 412)